146 related articles for article (PubMed ID: 29536181)
21. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
van Baarle D; Hovenkamp E; Callan MF; Wolthers KC; Kostense S; Tan LC; Niesters HG; Osterhaus AD; McMichael AJ; van Oers MH; Miedema F
Blood; 2001 Jul; 98(1):146-55. PubMed ID: 11418474
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C
Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
[TBL] [Abstract][Full Text] [Related]
24. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM
Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335
[TBL] [Abstract][Full Text] [Related]
25. Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.
Muncunill J; Baptista MJ; Hernandez-Rodríguez Á; Dalmau J; Garcia O; Tapia G; Moreno M; Sancho JM; Martínez-Picado J; Feliu E; Mate JL; Ribera JM; Navarro JT
Clin Infect Dis; 2019 Feb; 68(5):834-843. PubMed ID: 29982484
[TBL] [Abstract][Full Text] [Related]
26. Cell-free epstein-barr viral loads in childhood hodgkin lymphoma: a study from South India.
Sinha M; Rao CR; Shafiulla M; Appaji L; Bs AK; Sumati BG; Avinash T; Jayshree RS
Pediatr Hematol Oncol; 2013 Sep; 30(6):537-43. PubMed ID: 23756088
[TBL] [Abstract][Full Text] [Related]
27. Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients.
Navarro JT; Hernández A; Rodríguez-Manzano J; Mate JL; Grau J; Morgades M; Martró E; Tural C; Ribera JM; Matas L
Med Clin (Barc); 2010 Oct; 135(11):485-90. PubMed ID: 20673682
[TBL] [Abstract][Full Text] [Related]
28. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Kanakry JA; Li H; Gellert LL; Lemas MV; Hsieh WS; Hong F; Tan KL; Gascoyne RD; Gordon LI; Fisher RI; Bartlett NL; Stiff P; Cheson BD; Advani R; Miller TP; Kahl BS; Horning SJ; Ambinder RF
Blood; 2013 May; 121(18):3547-53. PubMed ID: 23386127
[TBL] [Abstract][Full Text] [Related]
29. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
[TBL] [Abstract][Full Text] [Related]
32. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients.
Okamoto A; Yanada M; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
Hematol Oncol; 2017 Mar; 35(1):87-93. PubMed ID: 26177728
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
36. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
[TBL] [Abstract][Full Text] [Related]
37. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus DNA in serum in a HIV-infected patient during development and treatment of non-Hodgkin's lymphoma.
Fleisch F; Reinhart WH; Brand B; Berger C
Swiss Med Wkly; 2005 Apr; 135(17-18):263-5. PubMed ID: 15965829
[TBL] [Abstract][Full Text] [Related]
39. γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation.
Pratesi C; Zanussi S; Tedeschi R; Bortolin MT; Talamini R; Rupolo M; Scaini C; Basaglia G; Di Maso M; Mazzucato M; Zanet E; Tirelli U; Michieli M; Carbone A; De Paoli P
PLoS One; 2015; 10(2):e0116887. PubMed ID: 25668032
[TBL] [Abstract][Full Text] [Related]
40. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Tirelli U; Errante D; Dolcetti R; Gloghini A; Serraino D; Vaccher E; Franceschi S; Boiocchi M; Carbone A
J Clin Oncol; 1995 Jul; 13(7):1758-67. PubMed ID: 7541452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
